A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®

Summary

This was a 3-year, prospective, multi-center, open-label study to describe the long term changes of optical coherence tomography (OCT) parameters in RRMS patients under treatment with Fingolimod. It was designed to longitudinally study the degeneration of retinal axons by measuring change in RNFL thickness by latest OCT-technology.

Timeline

Start

2012-08-20

Primary completion

2019-02-18

Completion

2019-02-18

Drugs

Indications